D Cobden

1.1k total citations
22 papers, 975 citations indexed

About

D Cobden is a scholar working on Endocrinology, Diabetes and Metabolism, Family Practice and Economics and Econometrics. According to data from OpenAlex, D Cobden has authored 22 papers receiving a total of 975 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Endocrinology, Diabetes and Metabolism, 10 papers in Family Practice and 4 papers in Economics and Econometrics. Recurrent topics in D Cobden's work include Diabetes Management and Research (13 papers), Diabetes Treatment and Management (10 papers) and Medication Adherence and Compliance (10 papers). D Cobden is often cited by papers focused on Diabetes Management and Research (13 papers), Diabetes Treatment and Management (10 papers) and Medication Adherence and Compliance (10 papers). D Cobden collaborates with scholars based in United States, Netherlands and Denmark. D Cobden's co-authors include Ashish V. Joshi, Chris L. Pashos, Won Chan Lee, Sanjeev Balu, L Nicklasson, Andrew Palmer, William J. Valentine, Joshua Ray, Manjiri Pawaskar and Fabian Camacho and has published in prestigious journals such as Diabetes Obesity and Metabolism, Health and Quality of Life Outcomes and Clinical Therapeutics.

In The Last Decade

D Cobden

22 papers receiving 907 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
D Cobden United States	16	742	226	134	103	90	22	975
Mette Bøgelund Denmark	17	522 0.7×	43 0.2×	86 0.6×	135 1.3×	167 1.9×	46	877
Christopher M. Dezii United States	11	272 0.4×	182 0.8×	6 0.0×	107 1.0×	76 0.8×	20	991
Rachel Bensen United States	10	236 0.3×	13 0.1×	278 2.1×	165 1.6×	45 0.5×	29	728
Tam Dang‐Tan United States	13	252 0.3×	19 0.1×	25 0.2×	98 1.0×	25 0.3×	27	880
Xinyang Hua Australia	13	93 0.1×	22 0.1×	34 0.3×	60 0.6×	93 1.0×	25	452
Autumn D. Zuckerman United States	12	21 0.0×	216 1.0×	41 0.3×	99 1.0×	190 2.1×	71	599
Giulio Formoso Italy	10	103 0.1×	16 0.1×	83 0.6×	30 0.3×	40 0.4×	21	395
Ayano Kelly Australia	11	120 0.2×	25 0.1×	12 0.1×	80 0.8×	32 0.4×	30	410
Iñaki Imaz-Iglesia Spain	12	66 0.1×	27 0.1×	16 0.1×	104 1.0×	65 0.7×	32	760

Countries citing papers authored by D Cobden

Since Specialization

Citations

This map shows the geographic impact of D Cobden's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D Cobden with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D Cobden more than expected).

Fields of papers citing papers by D Cobden

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D Cobden. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D Cobden. The network helps show where D Cobden may publish in the future.

Co-authorship network of co-authors of D Cobden

This figure shows the co-authorship network connecting the top 25 collaborators of D Cobden. A scholar is included among the top collaborators of D Cobden based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D Cobden. D Cobden is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Bhalla, Narinder, et al.. (2021). Hospitalization for Myocardial Infarction with Ticagrelor or Clopidogrel in Patients with Acute Coronary Syndrome: An On-Treatment Comparative Effectiveness Analysis. Cardiology and Therapy. 10(2). 515–529. 1 indexed citations

Wright, Eric A., et al.. (2017). Medication burden in patients with acute coronary syndromes.. PubMed. 23(4). e106–e112. 4 indexed citations

McAdam‐Marx, Carrie, et al.. (2016). Glycemic Control and Weight Outcomes for Exenatide Once Weekly Versus Liraglutide in Patients with Type 2 Diabetes: A 1-Year Retrospective Cohort Analysis. Clinical Therapeutics. 38(12). 2642–2651. 18 indexed citations

Nguyen, Hannah, et al.. (2015). Effect of Daily or weekly Glp-1 receptor Agonists on glycemic Control In Insulin-NaÏVe patients With Poorly Controlled type 2 Diabetes: a real-world study. Value in Health. 18(3). A54–A54. 3 indexed citations

Cobden, D. (2010). Modeling the economic impact of medication adherence in type 2 diabetes: a theoretical approach. Patient Preference and Adherence. 4. 283–283. 7 indexed citations

Cobden, D, Louis Niessen, Charles E. Barr, Frans Rutten, & Ken Redekop. (2009). Relationships among Self-Management, Patient Perceptions of Care, and Health Economic Outcomes for Decision-Making and Clinical Practice in Type 2 Diabetes. Value in Health. 13(1). 138–147. 32 indexed citations

Shulman, L.P., David Portman, Won Chan Lee, et al.. (2008). A Retrospective Managed Care Claims Data Analysis of Medication Adherence to Vaginal Estrogen Therapy: Implications for Clinical Practice. Journal of Women s Health. 17(4). 569–578. 41 indexed citations

Brod, Meryl, D Cobden, Morten Lammert, Donald M. Bushnell, & Philip Raskin. (2007). Examining correlates of treatment satisfaction for injectable insulin in type 2 diabetes: lessons learned from a clinical trial comparing biphasic and basal analogues. Health and Quality of Life Outcomes. 5(1). 8–8. 51 indexed citations

Valentine, William J., Katrina Erny-Albrecht, Joshua Ray, et al.. (2007). Therapy conversion to insulin detemir among patients with type 2 diabetes treated with oral agents: A modeling study of cost-effectiveness in the United States. Advances in Therapy. 24(2). 273–290. 18 indexed citations

10.

Cobden, D, Won Chan Lee, Sanjeev Balu, Ashish V. Joshi, & Chris L. Pashos. (2007). Health Outcomes and Economic Impact of Therapy Conversion to a Biphasic Insulin Analog Pen Among Privately Insured Patients with Type 2 Diabetes Mellitus. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 27(7). 948–962. 74 indexed citations

11.

Pawaskar, Manjiri, Fabian Camacho, Roger T. Anderson, et al.. (2007). Health Care Costs and Medication Adherence Associated with Initiation of Insulin Pen Therapy in Medicaid-Enrolled Patients with Type 2 Diabetes: A Retrospective Database Analysis. Clinical Therapeutics. 29(6). 1294–1305. 98 indexed citations

12.

Gilmer, Todd, Stéphane Roze, William J. Valentine, et al.. (2007). Cost‐Effectiveness of Diabetes Case Management for Low‐Income Populations. Health Services Research. 42(5). 1943–1959. 63 indexed citations

13.

Lee, Wen‐Chung, et al.. (2007). PDB13 COPAYMENT LEVEL AND MEDICATION ADHERENCE IN TYPE 2 DIABETES PATIENTS MANAGED WITH INSULIN ASPART PEN THERAPY. Value in Health. 10(3). A63–A63. 1 indexed citations

14.

Ray, Joshua, William J. Valentine, S Roze, et al.. (2006). Insulin therapy in type 2 diabetes patients failing oral agents: cost‐effectiveness of biphasic insulin aspart 70/30 vs. insulin glargine in the US*. Diabetes Obesity and Metabolism. 9(1). 103–113. 23 indexed citations

15.

Valentine, William J., Andrew Palmer, L Nicklasson, D Cobden, & S Roze. (2006). Improving life expectancy and decreasing the incidence of complications associated with type 2 diabetes: a modelling study of HbA1c targets. International Journal of Clinical Practice. 60(9). 1138–1145. 40 indexed citations

16.

Lee, Won Chan, Sanjeev Balu, D Cobden, Ashish V. Joshi, & Chris L. Pashos. (2006). Medication adherence and the associated health-economic impact among patients with type 2 diabetes mellitus converting to insulin pen therapy: An analysis of third-party managed care claims data. Clinical Therapeutics. 28(10). 1712–1725. 230 indexed citations

17.

Valentine, William J., Andrew Palmer, Katrina Erny-Albrecht, et al.. (2006). Cost-effectiveness of basal insulin from a US health system perspective: Comparative analyses of detemir, glargine, and NPH. Advances in Therapy. 23(2). 191–207. 35 indexed citations

18.

Stockl, Karen M., Ann Vanderplas, L Nicklasson, et al.. (2006). An evaluation of patient preference for an alternative insulin delivery system compared to standard vial and syringe. Current Medical Research and Opinion. 23(1). 133–146. 59 indexed citations

19.

Lee, Jennifer M., Marc Botteman, L Nicklasson, D Cobden, & Chris L. Pashos. (2005). Needlestick injury in acute care nurses caring for patients with diabetes mellitus: a retrospective study. Current Medical Research and Opinion. 21(5). 741–747. 51 indexed citations

20.

Lee, Won Chan, L Nicklasson, D Cobden, et al.. (2005). Short-term economic impact associated with occupational needlestick injuries among acute care nurses. Current Medical Research and Opinion. 21(12). 1915–1922. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact